Novorex Inc.

Novorex Inc. is a biotechnology research company dedicated to accelerating drug discovery through cutting-edge science and technology. Specializing in the development of new small molecule drugs, Novorex Inc. primarily targets oncology and neurology diseases, leveraging fragment-based drug discovery (FBDD) and artificial intelligence with the expertise of seasoned pharmaceutical professionals. The company performs seamless drug discovery, employing advanced technology that considers the entire process of new drug development.

Located at Primary: 240 Pangyoyeok-ro, #302 Samhwan HIPEX A, Bundang-gu, Seongnam-si, Gyeonggi-do, KR, Novorex Inc. aims to develop high-efficiency new drugs through drug design that combines biophysical analysis and in vitro/in vivo assays. This comprehensive approach ensures that each drug candidate is rigorously evaluated and optimized for maximum efficacy and safety.

Novorex Inc. is committed to innovation and excellence in biotechnology, striving to make a significant impact on the treatment of critical diseases. With a focus on integrating advanced technologies and pharmaceutical expertise, Novorex Inc. is well-positioned to drive advancements in drug discovery and development. We invite the management team at Novorex Inc. to create a customized and exclusive company showcase and product listing on our platform.